Reduce the Appearance of Age Lines with JUVÉDERM VOLUMA XC
What is JUVÉDERM VOLUMA™ XC?
JUVÉDERM VOLUMA™ XC is an injectable gel for deep injection in the cheek area to correct age-related volume loss in adults over the age of 21.
As we age, our skin gradually loses volume, contributing to less full-looking cheeks and more prominent lines and wrinkles throughout your face. Although entirely natural, visible signs of aging can leave you looking older than you feel. If you’ve struggled to accept your wrinkles, know you’re not alone—and you’re not out of luck. There is a simple way to help improve the appearance of fine lines and wrinkles without harsh chemical treatments or the use of Botox. This method is known as JUVÉDERM VOLUMA XC, and it may be the answer you’ve been looking for. This injectable gel is specifically formulated for deep injection in the cheek area, helping correct age-related volume loss in adults over the age of 21.
What is JUVÉDERM VOLUMA XC and how is it different from Botox?
JUVÉDERM is a natural product formulated to help rebuild volume to reduce the appearance of fine lines and wrinkles caused by aging. The process works by injecting a thick gel into the cheek and around the cheekbones. The gel helps lift the skin without damaging the healthy skin cells at the site. While you will see immediate results, you’ll notice the largest improvement a few weeks after your initial treatment. This allows the changes you’ll see in your face appear more natural and less forced, and thus more youthful.
Botox, on the other hand, is a toxin that paralyzes the muscles that cause wrinkles and fine lines. While it does work to visibly reduce signs of aging, it leaves you unable to fully express your emotions by raising an eyebrow or smiling fully. Botox is derived from botulin, a bacterial toxin that, in small amounts, provides temporary anti-aging effects. When used properly, it should not pose a health hazard, but the effects appear synthetic: Everyone will know you received a treatment the moment the injection starts working.
JUVÉDERM VOLUMA XC is different from JUVÉDERM
Though both JUVÉDERM VOLUMA XC and standard JUVÉDERM treat the appearance of fine lines, they target different areas. JUVÉDERM VOLUMA is ideal for patients concerned about the volume of their cheeks, while JUVÉDERM works best in the lip and chin areas, restoring volume to your grin and lip line. The two formulas differ in consistency and elasticity, so they cannot be used interchangeably. Prior to scheduling a treatment, you’ll want to speak with your dermatologist at Swyner-Woseth Dermatology to discuss the areas you’re most concerned about.
Regardless of which solution you use or where the injection is applied, you’ll receive long-lasting results that will help give you a youthful look for up to two years. Best of all, there’s little to no downtime after the procedure, so you can immediately enjoy the feeling of a vibrant complexion. With so many benefits, why settle for unwanted lines and wrinkles when you can immediately reduce the signs of aging with a simple procedure?
Don’t wait. Contact us today to schedule a consultation!
JUVÉDERM VOLUMA™ XC Important Information
JUVÉDERM VOLUMA™ XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
Important safety information
JUVÉDERM VOLUMA™ XC is contraindicated for patients with severe allergies, manifested by a history of anaphylaxis or history or presence of multiple severe allergies, and a history of allergies to gram-positive bacterial proteins or lidocaine.
JUVÉDERM VOLUMA™ XC injectable gel must not be injected into blood vessels and should not be used in vascular-rich areas. Use in these areas, such as glabella and nose, has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or infarction, or blindness. Symptoms of vessel occlusion and embolization include pain that is disproportionate to the procedure or remote to the injection site, immediate blanching extending beyond the injected area, and color changes that reflect ischemic tissue such as a dusky or reticular appearance
Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled
The safety and effectiveness for the treatment of anatomic regions other than the mid-face have not been established
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
The safety for use during pregnancy, in breastfeeding females, and in patients with very thin skin in the mid-face region has not been established
The safety for use in patients under 35 years or over 65 years has not been established
JUVÉDERM VOLUMA™ XC The safety in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
JUVÉDERM VOLUMA™ XC injectable gel should be used with caution in patients on immunosuppressive therapy
Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
Patients who experience skin injury near the site of JUVÉDERM VOLUMA™ XC implantation may be at a higher risk for adverse events
Patients may experience late onset nodules with use of dermal fillers including JUVÉDERM VOLUMA™ XC
Patients should be limited to 20 mL of JUVÉDERM VOLUMA™ XC per 60 kg (130 lbs) body mass per year. The safety of injecting greater amounts has not been established
JUVÉDERM VOLUMA™ XC should only be used by physicians who have appropriate experience and who are knowledgeable about facial anatomy and the product for use in deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation
Side effects in > 5% of subjects were temporary injection-site tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. They were predominantly moderate in severity, with a duration of 2 to 4 weeks.
To report an adverse reaction, please call Allergan Product Surveillance at 1-877-345-5372.
Juvéderm Voluma™ XC injectable gel is available by prescription only.